Search results
Avalon GloboCare—expanding horizons in cancer immunotherapy and cellular medicine
Nature· 23 hours agoAvalon’s immune effector cell cancer therapy candidates include both autologous and next-generation off-the-shelf (universal) chimeric antigen receptor (CAR) T cell therapies ...
Leveraging the full power of T cells to fight solid tumors
Nature· 23 hours agoImmatics is a clinical-stage biopharmaceutical company at the forefront of the discovery and development of T cell–based immunotherapies to treat cancer. Its mission is to ...
Revving up CAR T and gene therapy development for cancer
Nature· 23 hours agoMustang Bio is developing next-generation CAR T and gene therapies for cancer and rare genetic diseases, with lead clinical programs in non-Hodgkin lymphoma, chronic lymphocytic ...
Saving lives by preventing metastases
Nature· 23 hours agoCell division is a prerequisite for life and for growth. In cancer, it gets out of control, becoming a threat to life. About 19 million new cancer cases ...
A paradigm shift in the fight against cancer
Nature· 23 hours agoCould immediate tumor destruction paired with a new class of drugs deliver clinically meaningful benefit to patients with solid tumor cancers? Together...
Alternative medicine chief sets research agenda - Nature Medicine
Nature· 24 hours agoA report in The Washington Post pointed to a suspicion that the trial of an alternative medicine regimen, known as the Gonzalez treatment, was funded because of political pressure from congress ...
Oral bisphosphonate use may protect women from breast cancer - Nature Reviews Clinical Oncology
Nature· 24 hours agoBisphosphonates are commonly prescribed for the treatment of osteoporosis and for the prevention of cancer-induced bone loss. Interest ...
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving...
Nature· 1 day agoNo toxicities resulted from the treatment and in all 12 patients the number of peripheral neutrophils increased rapidly to a maximum of 100 x 10(9) l-1 ...
In this issue - Nature Reviews Drug Discovery
Nature· 1 day agoPromising targets for the treatment of other psychiatric and neurological conditions are considered in two review articles in this issue: Schoepp and colleagues ...
Patent watch - Nature Reviews Drug Discovery
Nature· 1 day agoThe disputed patent (IN 196774) for Tarceva — an epidermal growth factor receptor type 1 (EGFR1) inhibitor that is used for the treatment of non-small-cell ...
